Literature DB >> 17697999

Ligand-induced structural transitions in ErbB receptor extracellular domains.

Jessica P Dawson1, Zimei Bu, Mark A Lemmon.   

Abstract

Crystallographic studies showed that epidermal growth factor (EGF) receptor activation involves major domain rearrangements. Without bound ligand, the extracellular region of the receptor (sEGFR) adopts a "tethered" configuration with its dimerization site occluded by apparently autoinhibitory intramolecular interactions. Ligand binding causes the receptor to become "extended," breaking the tether and exposing the dimerization site. Using small-angle X-ray scattering (SAXS), we confirm that the tethered and extended conformations are also adopted in solution, and we describe low-resolution molecular envelopes for an intact sEGFR dimer. We also use SAXS to monitor directly the transition from a tethered to extended configuration in the monomeric extracellular regions of ErbB3 and a dimerization-defective EGFR mutant. Finally, we show that mutating every intramolecular tether interaction in sEGFR does not greatly alter its conformation. These findings explain why tether mutants fail to activate EGF receptor and provide new insight into regulation of ErbB receptor conformation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697999     DOI: 10.1016/j.str.2007.06.013

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  52 in total

1.  Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization.

Authors:  Zhiyong Zhang; Willy Wriggers
Journal:  Biochemistry       Date:  2011-02-18       Impact factor: 3.162

2.  Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients.

Authors:  Jon A Kenniston; Mark A Lemmon
Journal:  EMBO J       Date:  2010-08-10       Impact factor: 11.598

3.  The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction.

Authors:  Sangeeta Adak; Diana DeAndrade; Linda J Pike
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

4.  Matriptase is involved in ErbB-2-induced prostate cancer cell invasion.

Authors:  Shang-Ru Wu; Tai-Shan Cheng; Wen-Chi Chen; Hsin-Yi Shyu; Chun-Jung Ko; Hsiang-Po Huang; Chen-Hsin Teng; Chia-Hau Lin; Michael D Johnson; Chen-Yong Lin; Ming-Shyue Lee
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

5.  The ErbB4 extracellular region retains a tethered-like conformation in the absence of the tether.

Authors:  Ping Liu; Samuel Bouyain; Charles Eigenbrot; Daniel J Leahy
Journal:  Protein Sci       Date:  2011-11-14       Impact factor: 6.725

Review 6.  Transmembrane helix-helix interactions involved in ErbB receptor signaling.

Authors:  Florian Cymer; Dirk Schneider
Journal:  Cell Adh Migr       Date:  2010-04-13       Impact factor: 3.405

Review 7.  Insulin and epidermal growth factor receptor family members share parallel activation mechanisms.

Authors:  Kathryn M Ferguson; Chun Hu; Mark A Lemmon
Journal:  Protein Sci       Date:  2020-04-28       Impact factor: 6.725

8.  Suppression of heregulin β signaling by the single N-glycan deletion mutant of soluble ErbB3 protein.

Authors:  Motoko Takahashi; Yoshihiro Hasegawa; Yoshitaka Ikeda; Yoshinao Wada; Michiko Tajiri; Shigeru Ariki; Rina Takamiya; Chiaki Nishitani; Motoko Araki; Yoshiki Yamaguchi; Naoyuki Taniguchi; Yoshio Kuroki
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

Review 9.  Interaction of antibodies with ErbB receptor extracellular regions.

Authors:  Karl R Schmitz; Kathryn M Ferguson
Journal:  Exp Cell Res       Date:  2008-10-22       Impact factor: 3.905

10.  ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor.

Authors:  Diego Alvarado; Daryl E Klein; Mark A Lemmon
Journal:  Nature       Date:  2009-08-30       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.